According to CIP Consulting's forecast, the total profit of China's pharmaceutical industry will reach 578.02 billion RMB by 2025. Correspondingly, the intelligent upgrading of pharmaceutical enterprises has become a major approach to meeting market demand, and China's pharmaceutical industry is currently in a critical stage of intelligent upgrading.

With the continuous expansion of the industrial scale, pharmaceutical enterprises are facing multiple challenges in cost, efficiency and quality management. At present, most enterprises still rely on manual material handling, and the penetration rate of automated logistics remains low. There is an urgent need to realize automated, digitalized and clean management of material flow through AGV/AMR, especially in the links of raw materials, packaging materials and finished products.